Licensing Advantage Gives this Company a Leg Up in Potential $2.5 Trillion Mental Health Market

First-Mover Licensing Advantage Gives this Company a Leg Up in Potential $2.5 Trillion Mental Health Market
News Update 12-11-20:Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme
Numinus Wellness Inc. (OTC:LKYSF)(TSXV:NUMI) is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy. It…

Click here to view the original article.